560. Evaluation of Optimal Methylprednisolone Dose in Patients with Covid 19

BACKGROUND: Optimal dose of methylprednisolone in patients with moderate or severe COVID-19 is unclear. In our hospital, the use of 250-500 mg/day of methylprednisolone was frequent in the first wave of the pandemic. Lower dose were recommended in our protocol since September 2020. The aim was to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreiro, Jose Luis Lamas, Otero, Judith Álvarez, Piñeiro, Fernando Maroto, Ortega, Iolanda Abalde, Villar, Marta Rodríguez, Losada, Sonia Morón, González, Irea Vidal, Rico, Alejandra Canoa, González, Laura Fernández, Fernández, Emilia Fernández, Vila, Marta Costas, Rivo, Ana Sanjurjo, Fernández, Francisco Fernández, Paz Ferrín, Jose Manuel, Blanco, Alexandra Arca, Alonso, María, De la Fuente, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690601/
http://dx.doi.org/10.1093/ofid/ofab466.758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690601/
http://dx.doi.org/10.1093/ofid/ofab466.758

Ejemplares similares